4
Changes in Ownership
Stoke Therapeutics, Inc. Filed Acc 0001415889-25-008355
CEO acquired 61,750 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Kaye Edward M. MD CEO | 2025-03-15 | Option exercise | +35,500 | 132,385 | D | ||
| Kaye Edward M. MD CEO | 2025-03-15 | Option exercise | +26,250 | 158,635 | D | ||
| Derivatives | |||||||
| Kaye Edward M. MD CEO | 2025-03-15 | Option exercise · Restricted Stock Units | −35,500 | 71,000 | D | ||
| Kaye Edward M. MD CEO | 2025-03-15 | Option exercise · Restricted Stock Units | −26,250 | 78,750 | D | ||
Loading xslF345X05/form4-03182025_080305.xml…